speb/financial-data huggingface dataset:
BLSE.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 15127000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 15127000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 90738824.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.70
BLSE.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 154256000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — EBIT: 247804000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — EBITDA: 262931000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 1669537000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1669642000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 236123000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 236387000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 1870000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1870000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 9646000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5045514000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 143446000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 35052000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 35052000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 15071000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 412682000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -28545000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Income: 154256000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 154256000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 182801000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 154256000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 154256000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 182801000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -1870000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1870000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 236123000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3375872000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 3467000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 262931000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 154256000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Operating Income: 184855000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2697541000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 90856485.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 94498000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 252957000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 4136949000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 105000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: -200.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 62949000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 36405000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 118195000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3219499000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Payables: 560275000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 245934000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2461154000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 15127000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 90856485.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5045514000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3375872000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 63133000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 7170852000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5045514000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 74312000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5458196000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2512686000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1712656000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2165298000.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 56103000.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
BLSE.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
BLSE.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 3349001000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 70124000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2806764000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 91002878.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.39
BLSE.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2585714000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 15783000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 15783000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 91002878.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.39
BLSE.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 126494000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — EBIT: 211172000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — EBITDA: 226955000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 221050000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1661000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1661000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -25752000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Income: 126494000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 126494000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 152246000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 126494000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 126494000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 152246000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1661000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1661000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 226955000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 126494000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Operating Income: 150926000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2806764000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 60246000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 54341000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 209511000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2585714000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 15783000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 57265000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
BLSE.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2655838000.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
BLSE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BLSE.NS income_statement (annual, 2026-03-31) — +Operating Expense: 256719000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 74678000.00
BLSE.NS income_statement (annual, 2026-03-31) — +Total Revenue: 11177913000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3233729000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 820556000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 820556000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1192438000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1192438000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 160463000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 160463000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 90985185.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.62
BLSE.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 706781000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -88153000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 61320000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 61320000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 908565000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 908565000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 879312000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 879312000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4102272000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4102272000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -135893000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 2885000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -50256000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 75181000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Change In Payable: 260694000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -258151000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 42832000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 172531000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Common Stock: 908565000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 908565000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 5224725000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5224725000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 147683000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 147683000.00
BLSE.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 10235244000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2972452000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Current Assets: 5337567000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 5337567000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 35590000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 35590000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 35590000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 35590000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1871061000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1871061000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 7866000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 7866000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Depreciation: 62684000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 62684000.00
BLSE.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 62684000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 18059000.00
BLSE.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 62684000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 18059000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 90985185.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.62
BLSE.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 574964000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 147396000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 14000.00
BLSE.NS income_statement (annual, 2026-03-31) — EBIT: 935998000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — EBIT: 241644000.00
BLSE.NS income_statement (annual, 2026-03-31) — EBITDA: 998682000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — EBITDA: 259703000.00
BLSE.NS cash_flow (annual, 2026-03-31) — End Cash Position: 879312000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -191625000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 418674000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -35633000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Goodwill: 1669537000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 1669537000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1669627000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1669627000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 276426000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 276426000.00
BLSE.NS income_statement (annual, 2026-03-31) — Gross Profit: 942669000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 261277000.00
BLSE.NS income_statement (annual, 2026-03-31) — Interest Expense: 6701000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1414000.00
BLSE.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 6701000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1414000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -6700000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 46012000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Inventory: 1981000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1981000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 5224725000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5224725000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -142671000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 160463000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 160463000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 25730000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 25730000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 25730000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 25730000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 18213000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 18213000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 473415000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 473415000.00
BLSE.NS income_statement (annual, 2026-03-31) — Minority Interests: -117705000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -35008000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -264264000.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Income: 574964000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Income: 147396000.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 574964000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 147396000.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 692669000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 182404000.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 574964000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 147396000.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 574964000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 147396000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 929297000.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 692669000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 182404000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Interest Income: -6701000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1414000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 163720000.00
BLSE.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -6701000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1414000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Net PPE: 276426000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 276426000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -88153000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 3555098000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3555098000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 852000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 852000.00
BLSE.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 998682000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 259703000.00
BLSE.NS income_statement (annual, 2026-03-31) — Normalized Income: 574964000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 147396000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 506827000.00
BLSE.NS income_statement (annual, 2026-03-31) — Operating Income: 685950000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Operating Income: 186599000.00
BLSE.NS income_statement (annual, 2026-03-31) — Operating Revenue: 11177913000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 3233729000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 90654077.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 90654077.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 40876000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 40876000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 155601000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 155601000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 4316160000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 4316160000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 90000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 90000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -195797000.00
BLSE.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 250048000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 55045000.00
BLSE.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 194035000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 56619000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Other Properties: 128743000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 128743000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 3222960000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3222960000.00
BLSE.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Payables: 820556000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Payables: 820556000.00
BLSE.NS income_statement (annual, 2026-03-31) — Pretax Income: 929297000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 240230000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 0.00
BLSE.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -264264000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -120443000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -88153000.00
BLSE.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 10235244000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2972452000.00
BLSE.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 62684000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 18059000.00
BLSE.NS cash_flow (annual, 2026-03-31) — Sale Of Intangibles: 0.00
BLSE.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 284163000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Share Issued: 90856485.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 90856485.00
BLSE.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
BLSE.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 12182000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 5224725000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5224725000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 3555098000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3555098000.00
BLSE.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BLSE.NS income_statement (annual, 2026-03-31) — Tax Provision: 236628000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 57826000.00
BLSE.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
BLSE.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
BLSE.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -310368000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Total Assets: 7619204000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 7619204000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 5224725000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5224725000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Total Debt: 61320000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 61320000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 5698140000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5698140000.00
BLSE.NS income_statement (annual, 2026-03-31) — Total Expenses: 10491963000.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 3047130000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1921064000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1921064000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 2281637000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2281637000.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 50003000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 50003000.00
BLSE.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
BLSE.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BLSE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 202408.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 202408.00
BLSE.NS balance_sheet (annual, 2026-03-31) — Working Capital: 3466506000.00
BLSE.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 3466506000.00
BLSH balance_sheet (annual, 2021-12-31) — Accounts Payable: 33583000.00
BLSH income_statement (annual, 2021-12-31) — Basic Average Shares: 146183739.00
BLSH income_statement (annual, 2021-12-31) — Basic EPS: -9.59
BLSH cash_flow (annual, 2021-12-31) — Change In Account Payable: 33583000.00
BLSH cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
BLSH income_statement (annual, 2021-12-31) — Diluted Average Shares: 146183739.00
BLSH income_statement (annual, 2021-12-31) — Diluted EPS: -9.59
BLSH balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 0.00
BLSH balance_sheet (annual, 2021-12-31) — Finished Goods: 6110795000.00
BLSH cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 12000.00
BLSH income_statement (annual, 2021-12-31) — Interest Income: 1511000.00
BLSH income_statement (annual, 2021-12-31) — Interest Income Non Operating: 1511000.00
BLSH cash_flow (annual, 2021-12-31) — Interest Received Cfi: 1511000.00
BLSH cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
BLSH cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
BLSH cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -285000.00
BLSH cash_flow (annual, 2021-12-31) — Operating Gains Losses: 61000.00
BLSH balance_sheet (annual, 2021-12-31) — Other Equity Interest: 44795000.00
BLSH balance_sheet (annual, 2021-12-31) — Other Inventories: 6110795000.00
BLSH income_statement (annual, 2021-12-31) — Salaries And Wages: 59307000.00
BLSH cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
BLSH balance_sheet (annual, 2021-12-31) — Taxes Receivable: 12000.00
BLSH income_statement (annual, 2021-12-31) — Total Operating Income As Reported: -1275660000.00
BLSH balance_sheet (annual, 2021-12-31) — Total Tax Payable: 2044000.00
BLSH income_statement (annual, 2022-12-31) — +Operating Expense: -22224000.00
BLSH income_statement (annual, 2022-12-31) — +Total Revenue: 72895276000.00
BLSH balance_sheet (annual, 2022-12-31) — Accounts Payable: 66084000.00
BLSH balance_sheet (annual, 2022-12-31) — Accounts Receivable: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -4058000.00
BLSH balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 245802000.00
BLSH income_statement (annual, 2022-12-31) — Amortization: 0.00
BLSH cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 0.00
BLSH cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 0.00
BLSH income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 0.00
BLSH cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
BLSH income_statement (annual, 2022-12-31) — Basic Average Shares: 146183739.00
BLSH income_statement (annual, 2022-12-31) — Basic EPS: -29.04
BLSH cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1281015000.00
BLSH balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 16076000.00
BLSH cash_flow (annual, 2022-12-31) — Capital Expenditure: -1286000.00
BLSH balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 14128000.00
BLSH balance_sheet (annual, 2022-12-31) — Capital Stock: 3787108000.00
BLSH balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1383577000.00
BLSH balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1412471000.00
BLSH cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Cash Financial: 1383577000.00
BLSH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -7732000.00
BLSH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1286000.00
BLSH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 194925000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Account Payable: -3000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Inventory: 326795000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 46901000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 32504000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -3327000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Payable: -66855000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -66855000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Receivables: -83592000.00
BLSH cash_flow (annual, 2022-12-31) — Change In Working Capital: 252426000.00
BLSH cash_flow (annual, 2022-12-31) — Changes In Cash: 185907000.00
BLSH balance_sheet (annual, 2022-12-31) — Common Stock: 3787108000.00
BLSH cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1882836000.00
BLSH income_statement (annual, 2022-12-31) — Cost Of Revenue: 72901831000.00
BLSH balance_sheet (annual, 2022-12-31) — Current Assets: 3377535000.00
BLSH balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3222000.00
BLSH balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3222000.00
BLSH balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Current Liabilities: 1512161000.00
BLSH cash_flow (annual, 2022-12-31) — Depreciation: 3601000.00
BLSH cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3601000.00
BLSH income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 3601000.00
BLSH cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3601000.00
BLSH income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 3601000.00
BLSH income_statement (annual, 2022-12-31) — Depreciation Income Statement: 3601000.00
BLSH income_statement (annual, 2022-12-31) — Diluted Average Shares: 146183739.00
BLSH income_statement (annual, 2022-12-31) — Diluted EPS: -29.04
BLSH income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -4245884000.00
BLSH balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 7719000.00
BLSH income_statement (annual, 2022-12-31) — EBIT: -4121958000.00
BLSH income_statement (annual, 2022-12-31) — EBITDA: -4118357000.00
BLSH cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
BLSH cash_flow (annual, 2022-12-31) — End Cash Position: 1466922000.00
BLSH cash_flow (annual, 2022-12-31) — Financing Cash Flow: -7732000.00
BLSH balance_sheet (annual, 2022-12-31) — Finished Goods: 1658274000.00
BLSH cash_flow (annual, 2022-12-31) — Free Cash Flow: 193639000.00
BLSH cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 37000.00
BLSH income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -4137627000.00
BLSH balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
BLSH income_statement (annual, 2022-12-31) — General And Administrative Expense: 44417000.00
BLSH balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1336000.00
BLSH balance_sheet (annual, 2022-12-31) — Gross PPE: 21379000.00
BLSH income_statement (annual, 2022-12-31) — Gross Profit: -6555000.00
BLSH income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
BLSH income_statement (annual, 2022-12-31) — Interest Expense: 122726000.00
BLSH income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 122726000.00
BLSH cash_flow (annual, 2022-12-31) — Interest Paid Cff: -5435000.00
BLSH cash_flow (annual, 2022-12-31) — Interest Received Cfo: 4815000.00
BLSH balance_sheet (annual, 2022-12-31) — Inventory: 1658274000.00
BLSH balance_sheet (annual, 2022-12-31) — Invested Capital: 1882836000.00
BLSH cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1286000.00
BLSH cash_flow (annual, 2022-12-31) — Issuance Of Debt: 225000000.00
BLSH balance_sheet (annual, 2022-12-31) — Leases: 1344000.00
BLSH balance_sheet (annual, 2022-12-31) — Loans Receivable: 83592000.00
BLSH balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 10906000.00
BLSH balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 10906000.00
BLSH cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 225000000.00
BLSH cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -227297000.00
BLSH balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3959000.00
BLSH balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
BLSH income_statement (annual, 2022-12-31) — Minority Interests: 0.00
BLSH cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
BLSH cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 26000.00
BLSH income_statement (annual, 2022-12-31) — Net Income: -4245884000.00
BLSH income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -4245884000.00
BLSH income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -4245884000.00
BLSH income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -4245884000.00
BLSH income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -4245884000.00
BLSH cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -4245884000.00
BLSH income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -4245884000.00
BLSH cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
BLSH income_statement (annual, 2022-12-31) — Net Interest Income: -122726000.00
BLSH cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
BLSH cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2297000.00
BLSH cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -2297000.00
BLSH income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -122726000.00
BLSH balance_sheet (annual, 2022-12-31) — Net PPE: 17321000.00
BLSH cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1286000.00
BLSH balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1881500000.00
BLSH balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 97000.00
BLSH balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 5178000.00
BLSH balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 42000.00
BLSH balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 5178000.00
BLSH balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 42000.00
BLSH balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 855000.00
BLSH income_statement (annual, 2022-12-31) — Normalized EBITDA: 19270000.00
BLSH income_statement (annual, 2022-12-31) — Normalized Income: -977158670.00
BLSH cash_flow (annual, 2022-12-31) — Operating Cash Flow: 194925000.00
BLSH cash_flow (annual, 2022-12-31) — Operating Gains Losses: 63000.00
BLSH income_statement (annual, 2022-12-31) — Operating Income: 15669000.00
BLSH income_statement (annual, 2022-12-31) — Operating Revenue: 72895090000.00
BLSH balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 146183739.00
BLSH balance_sheet (annual, 2022-12-31) — Other Current Assets: 133012000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1415968000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Equity Interest: 62584000.00
BLSH income_statement (annual, 2022-12-31) — Other Gand A: 44417000.00
BLSH income_statement (annual, 2022-12-31) — Other Income Expense: -4137627000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1336000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Inventories: 1658274000.00
BLSH cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4162115000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 3768000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 145000.00
BLSH income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -4044293000.00
BLSH income_statement (annual, 2022-12-31) — Other Operating Expenses: -79498000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Payable: 18894000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Receivables: 3865000.00
BLSH balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 28894000.00
BLSH balance_sheet (annual, 2022-12-31) — Payables: 92971000.00
BLSH balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 92971000.00
BLSH balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Prepaid Assets: 6744000.00
BLSH income_statement (annual, 2022-12-31) — Pretax Income: -4244684000.00
BLSH balance_sheet (annual, 2022-12-31) — Properties: 0.00
BLSH cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
BLSH cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
BLSH cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
BLSH cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1286000.00
BLSH balance_sheet (annual, 2022-12-31) — Receivables: 87457000.00
BLSH income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 72901831000.00
BLSH income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3601000.00
BLSH cash_flow (annual, 2022-12-31) — Repayment Of Debt: -227297000.00
BLSH balance_sheet (annual, 2022-12-31) — Restricted Cash: 79577000.00
BLSH balance_sheet (annual, 2022-12-31) — Retained Earnings: -2212658000.00
BLSH cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 0.00
BLSH cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
BLSH cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
BLSH income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 9256000.00
BLSH income_statement (annual, 2022-12-31) — Selling General And Administration: 53673000.00
BLSH balance_sheet (annual, 2022-12-31) — Share Issued: 146183739.00
BLSH income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
BLSH cash_flow (annual, 2022-12-31) — Stock Based Compensation: 17789000.00
BLSH balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1882836000.00
BLSH balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1881500000.00
BLSH income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -868901670.00
BLSH income_statement (annual, 2022-12-31) — Tax Provision: 1200000.00
BLSH income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
BLSH balance_sheet (annual, 2022-12-31) — Total Assets: 3406090000.00
BLSH balance_sheet (annual, 2022-12-31) — Total Capitalization: 1882836000.00
BLSH balance_sheet (annual, 2022-12-31) — Total Debt: 14128000.00
BLSH balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1882836000.00
BLSH income_statement (annual, 2022-12-31) — Total Expenses: 72879607000.00
BLSH balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1523254000.00
BLSH balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 28555000.00
BLSH balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 11093000.00
BLSH balance_sheet (annual, 2022-12-31) — Total Tax Payable: 274000.00
BLSH income_statement (annual, 2022-12-31) — Total Unusual Items: -4137627000.00
BLSH income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -4137627000.00
BLSH cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
BLSH balance_sheet (annual, 2022-12-31) — Working Capital: 1865374000.00
BLSH income_statement (annual, 2023-12-31) — +Operating Expense: -31883000.00
BLSH income_statement (annual, 2023-12-31) — +Total Revenue: 116507500000.00
BLSH balance_sheet (annual, 2023-12-31) — Accounts Payable: 62000.00
BLSH balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2654000.00
BLSH balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -9481000.00
BLSH balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 18399000.00
BLSH income_statement (annual, 2023-12-31) — Amortization: 0.00
BLSH cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 0.00
BLSH cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 0.00
BLSH income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 0.00
BLSH cash_flow (annual, 2023-12-31) — Asset Impairment Charge: -1354190000.00
BLSH income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
BLSH income_statement (annual, 2023-12-31) — Basic Average Shares: 146183739.00
BLSH income_statement (annual, 2023-12-31) — Basic EPS: 8.89
BLSH cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1466922000.00
BLSH balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 16902000.00
BLSH cash_flow (annual, 2023-12-31) — Capital Expenditure: -966000.00
BLSH balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 11487000.00
BLSH balance_sheet (annual, 2023-12-31) — Capital Stock: 3787108000.00
BLSH balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 112901000.00
BLSH balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 367667000.00
BLSH cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -534644000.00
BLSH balance_sheet (annual, 2023-12-31) — Cash Financial: 112901000.00
BLSH cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -1212652000.00
BLSH cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 3924000.00
BLSH cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -126668000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Account Payable: 0.00
BLSH cash_flow (annual, 2023-12-31) — Change In Inventory: 139187000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -227638000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -66022000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 1463000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Payable: 96000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 96000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Receivables: 65896000.00
BLSH cash_flow (annual, 2023-12-31) — Change In Working Capital: -87018000.00
BLSH cash_flow (annual, 2023-12-31) — Changes In Cash: -1335396000.00
BLSH balance_sheet (annual, 2023-12-31) — Common Stock: 3787108000.00
BLSH cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -534644000.00
BLSH balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1281446000.00
BLSH cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
BLSH income_statement (annual, 2023-12-31) — Cost Of Revenue: 116529172000.00
BLSH balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 4867000.00
BLSH balance_sheet (annual, 2023-12-31) — Current Assets: 1705872000.00
BLSH balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3818000.00
BLSH balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 3818000.00
BLSH balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4568000.00
BLSH balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4568000.00
BLSH balance_sheet (annual, 2023-12-31) — Current Liabilities: 37738000.00
BLSH cash_flow (annual, 2023-12-31) — Depreciation: 5423000.00
BLSH cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 5423000.00
BLSH income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 5423000.00
BLSH cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 5423000.00
BLSH income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 5423000.00
BLSH income_statement (annual, 2023-12-31) — Depreciation Income Statement: 5423000.00
BLSH income_statement (annual, 2023-12-31) — Diluted Average Shares: 146183739.00
BLSH income_statement (annual, 2023-12-31) — Diluted EPS: 8.89
BLSH income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 1299167000.00
BLSH balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 4375000.00
BLSH income_statement (annual, 2023-12-31) — EBIT: 1304455000.00
BLSH income_statement (annual, 2023-12-31) — EBITDA: 1309878000.00
BLSH cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
BLSH cash_flow (annual, 2023-12-31) — End Cash Position: 131526000.00
BLSH cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1212652000.00
BLSH balance_sheet (annual, 2023-12-31) — Finished Goods: 1289346000.00
BLSH cash_flow (annual, 2023-12-31) — Free Cash Flow: -127634000.00
BLSH cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
BLSH income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1294244000.00
BLSH balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 142736000.00
BLSH income_statement (annual, 2023-12-31) — General And Administrative Expense: 13584000.00
BLSH balance_sheet (annual, 2023-12-31) — Goodwill: 40235000.00
BLSH balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 75171000.00
BLSH balance_sheet (annual, 2023-12-31) — Gross PPE: 23339000.00
BLSH income_statement (annual, 2023-12-31) — Gross Profit: -21672000.00
BLSH income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
BLSH income_statement (annual, 2023-12-31) — Interest Expense: 2983000.00
BLSH income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2983000.00
BLSH income_statement (annual, 2023-12-31) — Interest Income: 9224000.00
BLSH income_statement (annual, 2023-12-31) — Interest Income Non Operating: 9224000.00